David D Dore
Biographic Data
| ID | 5541600 |
|---|---|
| NAME | David D Dore |
| GIVEN NAMES | David D |
| FAMILY NAME | Dore |
| SIGNATURE | DORE D D |
| AFFILIATIONS | Brown University |
| ORCID | 0000-0003-0810-6662 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 0 |
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert
BACKGROUND: Responsiveness to the Food and Drug Administration (FDA) rosiglitazone safety alert, issued on May 21, 2007, has not been examined among vulnerable subpopulations of the elderly. OBJECTIVE: To compare time to discontinuation of rosiglitazone after the safety alert between black and white elderly persons, and across sociodemographic and economic subgroups. RESEARCH DESIGN: A cohort study. SUBJECTS: Medicare fee-for-service enrollees in…
No prominent works on this page.
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert
BACKGROUND: Responsiveness to the Food and Drug Administration (FDA) rosiglitazone safety alert, issued on May 21, 2007, has not been examined among vulnerable subpopulations of the elderly. OBJECTIVE: To compare time to discontinuation of rosiglitazone after the safety alert between black and white elderly persons, and across sociodemographic and economic subgroups. RESEARCH DESIGN: A cohort study. SUBJECTS: Medicare fee-for-service enrollees in…
Confidence interval (1 work) · Demography (1 work) · Discontinuation (1 work) · Emergency Medicine (1 work) · Emergency Medicine (1 work) · Hazard ratio (1 work) · Internal Medicine (1 work) · Internal Medicine (1 work) · Lipoproteins and Cardiovascular Health (1 work) · Medication Adherence and Compliance (1 work)